We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
+$25M
Cap. Flow %
1.92%
Top 10 Hldgs %
36.27%
Holding
543
New
63
Increased
193
Reduced
214
Closed
47

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$11.5M
2
SLV icon
iShares Silver Trust
SLV
+$7.75M
3
AMZN icon
Amazon
AMZN
+$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

Rank Sector Weight
1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QURE icon
326
uniQure
QURE
$3.13B
$243K 0.02%
10,150
+533
+6% +$20.6K
KOD icon
327
Kodiak Sciences
KOD
$2.72B
$242K 0.02%
+8,644
New +$177K
PGEN icon
328
Precigen
PGEN
$2.45B
$241K 0.02%
57,656
+5,426
+10% +$21K
RMD icon
329
ResMed
RMD
$32.8B
$241K 0.02%
+1,000
New +$256K
ORKA
330
Oruka Therapeutics
ORKA
$7.11B
$239K 0.02%
7,888
+1,323
+20% +$36.9K
UPB
331
Upstream Bio Inc
UPB
$378M
$239K 0.02%
+8,806
New +$219K
RLAY icon
332
Relay Therapeutics
RLAY
$4.4B
$239K 0.02%
28,243
-1,978
-7% -$14.1K
COLL icon
333
Collegium Pharmaceutical
COLL
$834M
$238K 0.02%
5,151
-371
-7% -$15.5K
ALV icon
334
Autoliv
ALV
$8.85B
$237K 0.02%
2,000
NVCR icon
335
NovoCure
NVCR
$2.05B
$236K 0.02%
18,247
-1,350
-7% -$17.3K
ARDX icon
336
Ardelyx
ARDX
$1.03B
$231K 0.02%
39,593
-2,648
-6% -$14.7K
TYRA icon
337
Tyra Biosciences
TYRA
$1.51B
$229K 0.02%
8,697
-645
-7% -$11.8K
AMLX icon
338
Amylyx Pharmaceuticals
AMLX
$2.6B
$216K 0.02%
17,895
+2,265
+14% +$30.8K
DFTX
339
Definium Therapeutics
DFTX
$5.75B
$215K 0.02%
16,052
+2,715
+20% +$33.6K
XERS icon
340
Xeris Biopharma Holdings
XERS
$1.55B
$212K 0.02%
27,037
-1,268
-4% -$9.98K
SIVR icon
341
abrdn Physical Silver Shares ETF
SIVR
$4.53B
$203K 0.02%
3,000
XPEV icon
342
XPeng
XPEV
$11.2B
$203K 0.02%
10,000
AMPH icon
343
Amphastar Pharmaceuticals
AMPH
$850M
$201K 0.02%
7,488
-662
-8% -$17.1K
SVRA icon
344
Savara
SVRA
$1.17B
$200K 0.02%
33,155
+2,859
+9% +$14K
VTYX
345
DELISTED
Ventyx Biosciences
VTYX
$195K 0.02%
+21,628
New +$162K
TNGX icon
346
Tango Therapeutics
TNGX
$4.31B
$194K 0.01%
21,946
+2,444
+13% +$21.1K
PHAT icon
347
Phathom Pharmaceuticals
PHAT
$742M
$192K 0.01%
11,592
-843
-7% -$12K
SPRY icon
348
ARS Pharmaceuticals
SPRY
$601M
$188K 0.01%
16,107
-1,216
-7% -$11.8K
INBX icon
349
Inhibrx
INBX
$1.44B
$187K 0.01%
2,370
-169
-7% -$11.5K
GRFS
350
Grifois
GRFS
$5.4B
$186K 0.01%
19,879
-1,505
-7% -$13.7K

Similar funds

China Universal Asset Management Company's Q4 2025 Portfolio in Review

As of Q4 2025, China Universal Asset Management Company held 543 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

China Universal Asset Management Company's Q4 2025 filing shows 63 new, 193 increased, 214 reduced and 47 closed positions. Its largest new stake was Western Digital: 13,175 shares worth $2.27M. The largest sale was Broadcom, an estimated $11.5M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.

  • China Universal Asset Management Company's largest Q4 2025 buy was Western Digital: 13,175 shares worth $2.27M.
  • China Universal Asset Management Company added most to ProShares Ultra Gold in Q4 2025, an estimated $16.2M increase.
  • China Universal Asset Management Company's biggest Q4 2025 reduction was Broadcom, cutting an estimated $11.5M.
  • China Universal Asset Management Company fully exited Royal Caribbean in Q4 2025, selling an estimated $2.72M.
  • China Universal Asset Management Company's ten largest holdings make up 36% of its $1.3B portfolio in Q4 2025.
  • China Universal Asset Management Company opened 63 new positions and closed 47 in Q4 2025.
  • China Universal Asset Management Company's portfolio value rose 7.6% quarter-over-quarter to $1.3B.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.